# Fragmin

NDC: 0069-0232
Generic name: Dalteparin Sodium
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20150401

FDA application: NDA020287

## Active ingredients

- DALTEPARIN SODIUM: 25000 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0232"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0232
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23527b8b-9b28-4e6d-9751-33b143975ac7